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Insulin stimulates glucose uptake into muscle and fat cells by promoting the translocation of glucose
transporter 4 (GLUT4) to the cell surface. Phosphatidylinositide 3-kinase (PI3K) has been implicated in this
process. However, the involvement of protein kinase B (PKB)/Akt, a downstream target of PI3K in regulation
of GLUT4 translocation, has been controversial. Here we report that microinjection of a PKB substrate peptide
or an antibody to PKB inhibited insulin-stimulated GLUT4 translocation to the plasma membrane by 66 or
56%, respectively. We further examined the activation of PKB isoforms following treatment of cells with insulin
or platelet-derived growth factor (PDGF) and found that PKBb is preferentially expressed in both rat and
3T3-L1 adipocytes, whereas PKBa expression is down-regulated in 3T3-L1 adipocytes. A switch in growth
factor response was also observed when 3T3-L1 fibroblasts were differentiated into adipocytes. While PDGF
was more efficacious than insulin in stimulating PKB phosphorylation in fibroblasts, PDGF did not stimulate
PKBb phosphorylation to any significant extent in adipocytes, as assessed by several methods. Moreover,
insulin, but not PDGF, stimulated the translocation of PKBb to the plasma membrane and high-density
microsome fractions of 3T3-L1 adipocytes. These results support a role for PKBb in insulin-stimulated glucose
transport in adipocytes.
The ability of insulin to promote glucose storage in muscle
and adipose tissue is crucial to the maintenance of glucose
homeostasis. An impairment in the ability of insulin to stimu-
late glucose uptake in these tissues, a condition termed insulin
resistance, contributes to the development of type 2 (non-
insulin-dependent) diabetes, hypertension, and cardiovascular
disease (25). The primary mechanism of insulin-stimulated
glucose uptake is through the translocation of glucose trans-
porter 4 (GLUT4) from an intracellular site to the cell surface
(26). Defects in the insulin signal transduction pathways that
regulate glucose transport have been considered likely causes
of insulin resistance (28).
While the insulin signaling pathways responsible for trigger-
ing GLUT4 translocation are yet to be defined, rapid progress
has been made. Activation of the insulin receptor results in the
tyrosyl phosphorylation of insulin receptor substrate (IRS)
proteins, docking proteins that recruit src homology 2-contain-
ing signaling proteins via phosphotyrosine moieties. Several
lines of evidence suggest the involvement of IRS proteins in
insulin-stimulated GLUT4 translocation. Disruption of IRS-1
and IRS-2 in mice causes mild insulin resistance and type 2
diabetes, respectively (6, 60). Overexpression of IRS-1 in rat
adipocytes mimics the effect of insulin on GLUT4 transloca-
tion (43), while reduction of IRS-1 by an antisense ribozyme
(43) or chronic insulin treatment (44) decreases insulin respon-
siveness. One of the molecules recruited by IRS proteins
thought to be required for insulin-stimulated GLUT4 translo-
cation is phosphatidylinositide 3-kinase (PI3K). Two inhibitors
of PI3K, wortmannin and LY294002, both inhibit insulin-stim-
ulated GLUT4 translocation (14, 17, 42). Furthermore, intro-
duction of a dominant negative p85 regulatory subunit into
adipocytes significantly impairs insulin-stimulated GLUT4
translocation either when microinjected (31) or when overex-
pressed (47). Overexpression of constitutively active p110 cat-
alytic subunit stimulates GLUT4 translocation to the plasma
membrane (PM) in the absence of insulin (38, 53). Hence,
these experiments collectively suggest that PI3K is necessary
for insulin-stimulated GLUT4 translocation.
Several protein serine/threonine kinases have recently been
identified as downstream targets of PI3K. These include pro-
tein kinase B (PKB; cellular homolog of v-AKT, also termed
RAC-PK) (11, 20, 22), PKCz (8, 50), and PKCl (32). Several
studies have examined the role of PKB in insulin-stimulated
GLUT4 translocation; however, the results have been some-
what contradictory. Constitutively active PKBa has been ex-
pressed in either 3T3-L1 adipocytes (30) or rat adipocytes (18,
54) and found to promote GLUT4 translocation to the plasma
membrane. Similarly, constitutively active PKBa increased glu-
cose uptake in L6 myotubes (23, 57). Studies utilizing domi-
nant negative PKB have produced conflicting results. In sup-
port of a role for PKB in insulin action, Cong et al. (18) found
that a kinase-inactive (K179A) PKBa mutant inhibited insulin-
stimulated GLUT4 translocation by 20% when transfected into
rat adipocytes. However, Hajduch et al. (23) found that this
same construct had no significant effect in L6 myotubes. Sim-
ilarly, two recent studies (29, 32) found that a double-phos-
phorylation site mutant of PKBa behaved as a dominant neg-
ative mutant with respect to 3T3-L1 adipocyte PKB activity
measured in vitro but had no significant effect on insulin-
stimulated GLUT4 translocation. In contrast, a kinase-inac-
tive, phosphorylation-deficient mutant of PKBa was found to
inhibit insulin-stimulated GLUT4 translocation in L6 myo-
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blasts (59). Part of the difficulty in reconciling these results lies
in the complexity of PKB regulation, which is only beginning to
be deciphered. The use of different cell types, some of which
may not be bona fide insulin-responsive cells, has also compli-
cated the interpretation. In addition, chronic overexpression of
mutant forms of PKB may enable the cell to adapt via alternate
pathways. Another potential problem is isoform specificity.
Three isoforms of PKB have been identified; however, these
were not distinguished in most studies examining the role of
PKB in insulin-stimulated glucose uptake. While all of the
PKB mutants studied were based on PKBa, PKBb was recently
identified as the isoform that associates with GLUT4 vesicles
in an insulin-dependent manner in rat adipocytes (12). Inter-
estingly, PKBb appears to be functionally distinct from PKBa
and PKBg, as stress activates PKBa and PKBg, but not PKBb
(48).
To further assess the role of PKB in insulin stimulation of
GLUT4 translocation, we have utilized a different approach
from previous studies. Microinjection of specific substrate pep-
tides and antibodies was used to acutely inhibit endogenous
PKB action. Microinjection of a PKB substrate peptide
(KRPRAATF) caused significant inhibition of insulin-stimu-
lated GLUT4 translocation in 3T3-L1 adipocytes. An antibody
directed against the N terminus of PKBa, which also recog-
nizes PKBb, produced similar effects. We further show that
PKBb expression is switched on during adipocyte differentia-
tion whereas PKBa is down-regulated. Concomitant with this
change, we also observed a switch in growth factor responsive-
ness during differentiation in that the ability of platelet-derived
growth factor (PDGF) to stimulate PKB phosphorylation is
switched off in adipocytes at the expense of a robust activation
by insulin. Taken together, our results strongly support PKBb
as the isoform involved in mediating the metabolic effects of
insulin in adipocytes.
MATERIALS AND METHODS
Antibodies. Rabbit antibodies directed against the N terminus of PKBa (res-
idues 3 to 22) were purchased from Santa Cruz Biotechnology (N19; Santa Cruz,
Calif.). Sheep antibodies against PKBa (residues 466 to 480), PKBb (residues
455 to 469, as described in reference 58), and PKBg (residues 116 to 128) were
purchased from Upstate Biotechnology Inc. (Lake Placid, N.Y.). Rabbit PKBb
antibodies were raised against a C-terminal peptide of PKBb (CDQTHFPQF-
SYSASIRE). Antibodies specific for PKB phosphorylated at Ser473 or Thr308
were purchased from New England Biolabs (Beverly, Mass.). Monoclonal anti-
hemagglutinin (anti-HA) antibodies (HA11, clone 16B12) were purchased from
BabCo (Berkeley, Calif.). Polyclonal anti-GLUT4 antibodies (R017) were raised
in rabbits against a 17-amino-acid peptide comprising the C terminus of GLUT4.
Peptide synthesis. Peptides were synthesized with an Applied Biosystems
430A Peptide synthesizer coupled with the FastMoc strategy. Purity was checked
by reverse-phase high-pressure liquid chromatography, and their integrity was
confirmed by amino acid analysis and matrix-assisted laser desorption ionization
mass spectrometry. Two peptides were examined. KRPRAATF was a peptide
closely related to that reported by Alessi et al. (1) as a specific substrate for PKB,
except that we included a lysine to increase its solubility in aqueous solutions.
KRPRAAAF was the same peptide, except that alanine was substituted for
threonine. The first peptide was found to be a good substrate for PKB in in vitro
assays. The alanine-substituted peptide partially inhibited PKB phosphorylation
of the substrate peptide only at the highest concentration tested (1 mg/ml) (data
not shown).
Cell culture. 3T3-L1 fibroblasts (American Type Culture Collection) were
grown and differentiated into adipocytes as described elsewhere (55). Briefly,
3T3-L1 fibroblasts were grown and passaged in Dulbecco’s modified Eagle me-
dium supplemented with 10% newborn calf serum. Cells were differentiated 1 to
2 days postconfluence. The differentiation medium contained 10% fetal calf
serum (FCS), 250 nM dexamethasone, 500 nM isobutyl methylxanthine, and 500
nM insulin. After 3 days, the differentiation medium was replaced with postdif-
ferentiation medium containing 10% FCS and 250 nM insulin. Cells were fed
every 3 days postdifferentiation in Dulbecco’s modified Eagle medium supple-
mented with 10% FCS. Unless otherwise stated, fibroblasts were used at con-
fluence and adipocytes were used at 8 to 15 days after the initiation of differen-
tiation. 3T3-L1 fibroblasts stably expressing HA-PKBa or HA-PKBb have been
described elsewhere (52).
Microinjection. Microinjection was performed as previously described (35).
Cells grown to confluence and differentiated on coverslips were transferred to
Krebs-Ringer bicarbonate buffer (111 mM NaCl, 4.87 mM KCl, 1.15 mM CaCl2,
1.22 mM KH2PO4, 1.21 mM MgSO4, 25.7 mM NaHCO3, 10 mM HEPES, 2.5
mM glucose, 0.5% bovine serum albumin [BSA], 1 mM Na pyruvate, pH 7.4) for
45 min. They were microinjected over a 45-min period with a Zeiss automated
injection system (Carl Zeiss, Oberkochen, Germany) coupled to an Eppendorf
(Hamburg, Germany) microinjector. Micropipettes were prepared with a Sutter
(Novato, Calif.) P-97 micropipette puller. Reagents for microinjection were
dissolved in microinjection buffer (5 mM sodium phosphate [pH 7.2] and 100
mM KCl). Sodium azide in the antibody preparation was removed by dialysis in
three changes of microinjection buffer. Cells were transferred into fresh medium
and allowed to recover for 60 to 90 min following injection of peptide (5 mg/ml)
or antibody (0.2 mg/ml), prior to stimulation with insulin (100 nM) and analysis
of GLUT4 translocation by the PM lawn assay.
PM lawn assay. GLUT4 translocation was determined by the PM lawn assay
as described by Robinson and James (46) with modifications described by Marsh
et al. (37). Briefly, 3T3-L1 cells grown on coverslips were washed in poly-L-lysine
after cell treatment, hypotonically shocked with three washes in one-third intra-
cellular buffer (70 mM KCl, 5 mM MgCl2, 3 mM EGTA, 1 mM dithiothreitol, 30
mM HEPES, pH 7.2), and sonicated with a probe sonicator (Microson, Farm-
ington, N.Y.) at setting 0 in intracellular buffer to generate a lawn of PM
fragments that remained attached to the coverslip. The fragments were then
immunolabeled with rabbit anti-GLUT4 antibodies (R1159) (27) and Cy3-la-
beled goat anti-rabbit antibodies (Amersham, Little Chalfont, United Kingdom).
Coverslips were visualized and imaged with a Bio-Rad Lasersharp MRC-500
confocal laser scanning immunofluorescence microscope. GLUT4 translocation
in microinjected cells was compared to that in noninjected cells in the immediate
vicinity on the same coverslip. Data was analyzed with Bio-Rad COMOS con-
focal imaging software. Six or more fields were analyzed for each condition
within each experiment.
Treatment of cells, metabolic labeling, and preparation of extracts. Differen-
tiated 3T3-L1 adipocytes were serum starved by incubating them in Krebs-
Ringer phosphate buffer (KRP) containing 12.5 mM HEPES (pH 7.4), 120 mM
NaCl, 6 mM KCl, 1.2 mM Mg2SO4, 1 mM CaCl2, 1 mM NaPO4, and 0.1%
(wt/vol) BSA for at least 2 h at 37°C prior to stimulation. Insulin (1 mM; Eli Lilly)
and PDGF (50 ng/ml; Gibco) treatments were for 5 or 15 min. Where indicated,
100 nM wortmannin (Sigma) was added to KRP 25 min prior to addition of
insulin. For metabolic labeling, cells were incubated in low (0.2 mM)-phosphate
KRP containing 0.5 mCi of 32Pi (ICN) per ml in place of the KRP incubation and
then treated as described above. After treatment, cells were washed three times
with ice-cold HES buffer (20 mM HEPES [pH 7.4], 1 mM EDTA, 250 mM
sucrose) and homogenized in HES buffer supplemented with protease inhibitors
(10 mg of aprotinin per ml, 10 mg of leupeptin per ml, and 1 mM phenylmeth-
ylsulfonyl fluoride) and phosphatase inhibitors (1 mM sodium orthovanadate, 1
mM sodium pyrophosphate, 1 mM ammonium molybdate, and 10 mM sodium
fluoride) by 15 passes through a 22-gauge needle. 3T3-L1 fibroblasts were har-
vested in the same manner, except that homogenization was done through a
27-gauge needle. Subcellular fractionation of 3T3-L1 adipocytes was performed
as described in the work of Clark et al. (16).
Preparation of primary rat adipocytes. Primary rat adipocytes were prepared
from epididymal fat pads of male Wistar rats (100 to 125 g) by the collagenase
digestion method (49). After incubation in KRP (containing 2% BSA) with
agitation for 1 h at 37°C, cells were treated with or without 1 mM insulin for 15
min. Adipocytes were collected by centrifugation and homogenized in HES
buffer with inhibitors by 15 passes through a 27-gauge needle.
Immunoprecipitation. Cells were harvested in lysis buffer (50 mM Tris [pH
7.5], 100 mM NaCl, 1% Triton X-100, 25 mM b-glycerophosphate, protease
inhibitors, and phosphatase inhibitors) and homogenized by 15 passes through a
22-gauge needle. After incubation on ice for 15 min, lysates were centrifuged at
12,800 3 g for 15 min at 4°C. Immunoprecipitation was performed by adding the
supernatants to Eppendorf tubes containing blocked, antibody-conjugated pro-
tein A-G beads (Pierce) and incubating them at 4°C with mixing for at least 2 h.
Immunocomplexes were collected by centrifugation and washed twice with cold
lysis buffer and once with low-salt buffer (10 mM NaCl, 10 mM Tris, pH 7.5).
Proteins bound were eluted by addition of gel sample buffer.
To characterize PKB antibodies and for PKBb immunodepletion experiments,
immunoprecipitation was performed by adding 100 mg of cell lysate (in HES
buffer) to radioimmunoprecipitation assay buffer (150 mM NaCl, 10 mM Tris
[pH 8], 1% Triton X-100, 1% sodium deoxycholate, and 0.1% sodium dodecyl
sulfate [SDS]) supplemented with protease inhibitors and phosphatase inhibitors
and incubating the lysate with antibody-conjugated protein A-G beads at 4°C.
For PKBb depletion experiments, the supernatants were subjected to a second
round of immunoprecipitation. To analyze the lysate after PKBb depletion, an
aliquot of the supernatant after immunoprecipitation was subjected to methanol-
chloroform precipitation (7). The resulting protein pellets were resuspended in
Laemmli sample buffer and analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE).
Electrophoresis and immunoblotting. Protein assays were performed using the
Bradford assay reagent (Bio-Rad) or the bicinchoninic acid protein assay kit
(Pierce), with BSA (fraction V; Pierce) as standard. SDS-PAGE was performed
according to the method of Laemmli (34), using the SE400 system (Hoefer).
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Two-dimensional gel electrophoresis (2-DE) with immobilized pH gradients
was performed exactly as described in the work of Hill et al. (24), with nonlinear
pH 3 to 10 immobilized pH gradients in the first dimension and SDS–7.5%
PAGE gels in the second dimension. To prepare samples for 2-DE, cell lysates
in HES buffer were precipitated with 4 volumes of methanol at 220°C for 1 h and
then centrifuged for 10 min at 10,000 3 g at room temperature. After the
supernatants were removed, the pellets were air dried and resolubilized in 2D
sample buffer (7 M urea, 2 M thiourea, 40 mM Tris, 4.4% 3-[(3-cholamidopro-
pyl)-dimethylammonio]-1-propanesulfonate [CHAPS], 84 mM dithiothreitol,
1% Pharmalyte, 0.01% bromophenol blue, 1 mM phenylmethylsulfonyl fluoride,
and phosphatase inhibitors as described above). Samples were sonicated in a
sonicating water bath (Branson) for 1 min at room temperature and then cen-
trifuged as before. The resulting supernatants were underlaid into oil-filled
sample cups positioned at the anode, and isoelectric point focusing was per-
formed for 53.5 kV z h at 20°C.
After electrophoresis, proteins were transferred onto polyvinylidene difluoride
membranes (Immobilon-P from Millipore) according to the method of Towbin et
al. (56). Membranes were blocked in 5% skim milk powder in Tris-buffered
saline–Tween (TBST; 50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% Tween 20) for
1 h at room temperature and then incubated with the relevant primary antibody
(diluted in blocking buffer or TBST) at 4°C overnight. After washing in TBST for
30 min with three changes of buffer, immunoreactive proteins were detected with
horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG),
goat anti-mouse IgG (Amersham), or rabbit anti-sheep IgG (Sigma) as appro-
priate and SuperSignal chemiluminescence substrate (Pierce). Images were cap-
tured on film (Fuji) or a Lumi-Imager (Boehringer).
RESULTS
Effect of a PKB substrate peptide or a PKB antibody on
insulin-stimulated GLUT4 translocation. Previous studies in-
vestigating the role of PKB in insulin-stimulated glucose trans-
port have utilized overexpression of either constitutively active
(18, 23, 30, 54, 57) or dominant negative (18, 23, 29, 32, 59)
mutants of PKBa. These studies have produced conflicting
results, and so we undertook a different approach to assess the
role of PKB in insulin-stimulated glucose transport. Firstly, we
have used microinjection in 3T3-L1 adipocytes. This approach
circumvents potential adaptive responses that may occur dur-
ing chronic overexpression of mutants, because we routinely
perform our analysis 60 to 90 min after microinjection. This
technique in combination with the PM lawn assay provides a
means for examining the effects of inhibitors in single cells.
Using this system, we routinely observe a 2.5-fold increase in
cell surface levels of GLUT4 in response to insulin in cells
microinjected with control peptides or control antibodies and
in neighboring noninjected cells. Microinjection was per-
formed with 3T3-L1 adipocytes with a peptide (KRPRAATF)
closely related to the peptide previously determined to be
relatively specific for PKB (1), except that a lysine was included
at the N terminus to increase its solubility. As shown in Fig. 1A,
the substrate peptide inhibited insulin-stimulated GLUT4
translocation by (66.1 6 7.8)% (n 5 10). A control peptide in
which alanine was substituted for the phosphorylation site
threonine had no significant effect on GLUT4 translocation
([7.3 6 3.7]%, n 5 6). This suggests that the injected substrate
peptide is interfering with the propagation of the signaling
pathway leading to GLUT4 translocation, probably by compet-
ing with a physiological substrate of PKB.
To further assess the role of PKB in insulin-stimulated
GLUT4 translocation, studies in which antibodies against PKB
were microinjected into 3T3-L1 adipocytes were performed.
An antibody directed against the N terminus of PKBa (N19
from Santa Cruz), which cross-reacts with PKBb, inhibited
insulin-stimulated GLUT4 translocation by (55.6 6 7.8)%
whereas an unrelated antibody had no significant effect on this
process (Fig. 1B). We also examined the effect of a variety of
C-terminal PKB antibodies, including the isoform-specific
sheep PKBb antibody described below. However, none of
these antibodies had a significant effect on insulin-stimulated
GLUT4 translocation in this system (data not shown). This
may indicate that the C terminus is inaccessible in vivo or that
antibody binding to this domain is less disruptive to PKB func-
tion.
Down-regulation of PDGF responsiveness in 3T3-L1 adipo-
cytes. The microinjection data indicates that activation of PKB
is necessary to fully mediate insulin-stimulated GLUT4 trans-
location in adipocytes. However, it has been reported that
PDGF also activates PKB in adipocytes without any significant
effect on GLUT4 translocation (10, 51, 54), raising the possi-
bility that PKB activation may not be sufficient for insulin
action. To explore this issue further, we have compared the
effects of insulin with those of PDGF on the activation of PKB
in 3T3-L1 adipocytes as well as their precursor cells, 3T3-L1
fibroblasts. As phosphorylation at Ser473 and Thr308 is essen-
tial for PKB activation, the effect of insulin and PDGF on PKB
phosphorylation in 3T3-L1 cells was initially examined by im-
munoblotting with phosphospecific PKB antibodies (Fig. 2A).
Treatment of 3T3-L1 fibroblasts with either insulin or PDGF
FIG. 1. Microinjection of PKB substrate peptide or an N-terminal PKB an-
tibody inhibits insulin-stimulated GLUT4 translocation. 3T3-L1 adipocytes on
coverslips were preincubated in Krebs-Ringer bicarbonate–HEPES buffer for 45
to 90 min. (A) Cells were then either not microinjected (Nil), microinjected with
PKB substrate peptide (KRPRAATF), or microinjected with control peptide
(KRPRAAAF) at 5 mg/ml. (B) 3T3-L1 adipocytes were either not injected (Nil)
or microinjected with a purified N-terminal PKB antibody (PKB Ab) (N19; Santa
Cruz) or purified rabbit IgG fraction (Control Ab) at 0.2 mg/ml. Bathing buffer
was changed, and the cells were allowed to recover for 60 min. Cells were then
stimulated or not with 100 nM insulin for 20 min prior to assessment of PM
GLUT4 levels by the PM lawn assay as described in Materials and Methods.
Results are from four or more experiments in which GLUT4 levels in six or more
fields were determined for each condition within each experiment. p, P , 0.01
compared with insulin stimulation (paired t test).
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for 15 min caused PKB phosphorylation on Ser473 and
Thr308, with PDGF being more efficacious than insulin (Fig.
2A). The response to insulin compared with that to PDGF in
3T3-L1 adipocytes was quite different from that of fibroblasts.
In this case, only insulin stimulated PKB phosphorylation, as
detected by phosphospecific PKB antibodies (Fig. 2A).
In order to correlate these results with phosphorylation of
specific PKB isoforms, the isoform specificity of PKB antibod-
ies was examined by immunoblotting using stable cell lines of
3T3-L1 fibroblasts expressing HA-tagged forms of PKBa or
PKBb. HA-tagged PKB was immunoprecipitated from lysates
with a monoclonal HA antibody and immunoblotted with a
panel of PKB antibodies. The sheep PKBb antibody immuno-
blotted HA-PKBb but exhibited no detectable cross-reactivity
with HA-PKBa (Fig. 2B). In contrast, the sheep PKBa anti-
body immunoblotted both HA-PKBa and HA-PKBb, and the
rabbit PKBb antibody showed a slight cross-reactivity with
HA-PKBa (Fig. 2B).
The above data suggests that the sheep PKBb antibody is
isoform specific, at least in immunoblotting; however, the
sheep PKBa antibody cross-reacts with PKBb to a consider-
able extent. Nevertheless, we proceeded to examine the rela-
tive expression and the effect of growth factors on the electro-
phoretic mobility of PKBa and PKBb by using the sheep PKB
antibodies. As shown in Fig. 2C, both sheep PKBa and PKBb
antibodies labeled bands in 3T3-L1 cells of an average molec-
ular mass of 60 kDa, consistent with the calculated molecular
mass of 56 kDa. While a single immunoreactive band was
detected in basal fibroblasts, an additional band with lower
molecular mass (band 0) was detected in basal adipocytes, with
either the PKBa or the PKBb antibody (Fig. 2C). The band
labeled with the PKBb antibody was up-regulated during the
differentiation process whereas the intensity of the band la-
beled by the PKBa antibody in fibroblasts was not significantly
different from the combined intensity of the two bands in
adipocytes (Fig. 2C). In agreement with results presented in
Fig. 2A, both insulin and PDGF caused an electrophoretic
mobility shift in PKB in fibroblasts, whereas only insulin
caused a shift in adipocytes. Interestingly, the electrophoretic
shift for both PKBa and PKBb was much more pronounced in
adipocytes than in fibroblasts. Moreover, in insulin-treated adi-
pocytes, band 0 was almost quantitatively shifted to a position
slightly above band 1 (labeled band 2) whereas the apparent
mobility and intensity of band 1 were unchanged (Fig. 2C).
PKBb is highly up-regulated during adipocyte differentia-
tion. Key molecules mediating insulin regulation of metabo-
lism are increased upon adipocyte differentiation. Thus, we
further examined the change in PKBb expression during the
differentiation process and found that the increase in PKBb
expression during differentiation closely paralleled that ob-
served for GLUT4 (Fig. 3A). The most dramatic increase in
both PKBb and GLUT4 occurred after day 6, when the dif-
ferentiation medium was removed and cells were fed with
medium supplemented only with 10% FCS (Fig. 3A). No
GLUT4 expression was detected prior to initiation of differ-
entiation (day 0, Fig. 3A). However, a low level of PKBb was
FIG. 2. Change in growth factor response accompanies differentiation of 3T3-L1 adipocytes. (A) Serum-starved 3T3-L1 fibroblasts or adipocytes were stimulated
with 1 mM insulin (I) or 50 ng of PDGF per ml (P) for 15 min or left untreated (B). Cell lysates (30 mg) were analyzed by SDS-PAGE and immunoblotting with
phospho-Ser473 (pSer473) or phospho-Thr308 (pThr308) PKB antibodies. (B) HA-PKBa or HA-PKBb was immunoprecipitated from lysates (100 mg) of 3T3-L1
fibroblasts expressing either HA-PKBa or HA-PKBb and analyzed by SDS-PAGE. Immunoblotting was performed with the sheep PKBa, the sheep PKBb, or the rabbit
PKBb antibodies. (C) Cell lysates (30 mg) prepared as described for panel A were analyzed by SDS-PAGE and immunoblotting with the sheep PKBa or the sheep
PKBb antibody. Bands labeled as band 1 exhibited the same electrophoretic mobility.
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detected (day 0, Fig. 3A). Preliminary experiments suggested
that there may be changes in PKBb expression associated with
cell confluency. This possibility was examined by immunoblot-
ting lysates harvested from 3T3-L1 fibroblasts at different con-
fluencies. As shown in Fig. 3B, no PKBb was detected in
fibroblasts at 50% confluence, but a low level of expression was
observed when 3T3-L1 fibroblasts reached confluence. Differ-
entiation into adipocytes, however, induced a much more sig-
nificant up-regulation of PKBb expression (Fig. 3B).
PKBa is down-regulated in adipocytes. The above data
clearly demonstrates an induction of PKBb expression during
adipocyte differentiation. However, while PKBa appears to be
highly expressed in fibroblasts, its expression in adipocytes is
not clear due to antibody cross-reactivity. Thus, to more clearly
determine PKBa expression, we performed immunoblotting
on cell lysates that had been depleted of PKBb with the spe-
cific sheep PKBb antibody. In agreement with Fig. 2C, prior to
PKBb immunodepletion, the PKBa antibody detected bands
with similar intensities in fibroblasts and adipocytes, while a
substantial induction of PKBb was observed in adipocytes (Fig.
4A). After immunodepletion with the sheep PKBb antibody,
almost all of the immunoreactive PKBb was removed from the
adipocyte lysate (Fig. 4A). When the same samples were im-
munoblotted with the PKBa antibody, there was little differ-
ence in the fibroblasts before and after PKBb immunodeple-
tion, suggesting that PKBa is expressed at high levels in
fibroblasts. However, there was a substantial reduction in im-
munolabeling with this antibody in adipocytes after PKBb de-
pletion, suggesting that most of the PKBa immunoreactivity is
due to PKBb in these cells and that PKBb is the predominant
isoform expressed in 3T3-L1 adipocytes (Fig. 4A). To deter-
mine if this is a general feature of adipocytes, we performed
similar experiments with primary cultures of adipocytes iso-
lated from rat fat. Prior to PKBb immunodepletion, both the
PKBa and the PKBb antibodies detected a band which showed
an electrophoretic mobility shift with insulin treatment (Fig.
4B). However, after PKBb depletion, no PKBa was detected in
rat adipocyte lysates, suggesting that these cells do not express
significant levels of PKBa (Fig. 4B).
One trivial explanation for these observations is that PKBa
and PKBb hetero-oligomerize and therefore all of the PKBa is
removed during PKBb immunodepletion. However, this seems
unlikely because interaction between PKB molecules has been
shown to be isoform specific, as the Akt homology domain of
PKBa coimmunoprecipitates PKBa but not PKBb (21). Nev-
ertheless, we addressed this possibility using 3T3-L1 adipocytes
overexpressing HA-PKBa. As shown in Fig. 4C, no signal
corresponding to HA-PKBa was detected in the PKBb immu-
noprecipitate, demonstrating that, under these conditions,
PKBa does not coimmunoprecipitate with PKBb.
Insulin but not PDGF stimulates PKBb phosphorylation in
3T3-L1 adipocytes. The above data suggests that PKBb is the
most pertinent isoform for the insulin-specific PKB phosphor-
ylation in 3T3-L1 adipocytes observed in Fig. 2A. To verify this
conclusion, we next examined the phosphorylation of PKB
isoforms following immunoprecipitation with isoform-specific
antibodies. To examine the extent of PKBa phosphorylation, it
was necessary to first deplete lysates of PKBb prior to immu-
noprecipitation with the PKBa antibody. In these experiments,
we also examined the effect of insulin and PDGF after 5 min of
stimulation, in order to assess if PDGF has a transient effect on
PKB activity. Insulin, but not PDGF, stimulated the phosphor-
ylation of immunoprecipitated PKBa in 3T3-L1 adipocytes as
detected by phospho-PKB antibodies (Fig. 5A). However, this
signal most likely represents residual PKBb that was immuno-
precipitated by the PKBa antibody (Fig. 5A). A marked in-
crease in PKBb phosphorylation was observed in response to
insulin, while PDGF had little effect on PKBb phosphorylation
at 5 or 15 min of stimulation (Fig. 5A). PKBb phosphorylation
was also directly examined by immunoprecipitation from
3T3-L1 adipocytes metabolically labeled with 32P (Fig. 5B). A
low level of constitutive phosphorylation was observed under
basal conditions, and insulin stimulation caused a threefold
increase in PKBb phosphorylation (Fig. 5B). Insulin-stimu-
lated phosphorylation was accompanied by an electrophoretic
mobility shift, and the shifted band was specifically detected by
phospho-Ser473 PKB antibodies (Fig. 5B). In agreement with
previous results (Fig. 2 and 5A), PDGF had no significant
effect on PKBb phosphorylation in 3T3-L1 adipocytes.
2-DE was used to further examine PKBb phosphorylation in
adipocytes. PKBb was immunoprecipitated from 32P-labeled
3T3-L1 adipocytes and then subjected to 2-DE and autora-
diography. Two spots of similar molecular masses but different
pIs were detected in basal adipocytes (spots 1 and 2, Fig. 6A).
The observed pI of these phosphospots was 5.6 to 5.8, which
agrees with that calculated for PKBb (5.9). The presence of the
FIG. 3. PKBb expression is induced upon adipocyte differentiation. (A)
3T3-L1 cells were harvested on each day of the differentiation procedure and
analyzed for the expression of PKBb (F) or GLUT4 (E) by immunoblotting with
the sheep PKBb antibody or a rabbit anti-GLUT4 antibody (R017), respectively.
Immunoreactive signal (obtained as Lumi-Imager units) was adjusted for total
protein obtained per sample and then expressed as a percentage of the maxi-
mum. Results are representative of two separate experiments. (B) 3T3-L1 fibro-
blasts were harvested at subconfluence (50% or 90%) or 1 day after reaching
confluence (post-conf.). 3T3-L1 adipocytes were harvested after completion of
differentiation, at day 8 (adip). Cell lysates (30 mg) were analyzed for the level of
PKBb expression by SDS-PAGE and immunoblotting with the sheep PKBb
antibody.
VOL. 19, 1999 PKBb IN INSULIN-STIMULATED GLUT4 TRANSLOCATION 7775
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
two phospho-PKBb spots is consistent with two sites of con-
stitutive phosphorylation, where spots 1 and 2 represent mono-
and dual-phosphorylated forms, respectively. Insulin stimula-
tion resulted in an increase in the intensity of spots 1 and 2, as
well as the 32P labeling of an additional spot (spot 3) of more
acidic pI (Fig. 6B). To determine the relative abundance of
differentially phosphorylated forms of PKBb, we performed
2D immunoblotting. In addition to spots 1 and 2, a spot at pI
6 in 2D blots of basal adipocyte lysate which represents un-
phosphorylated PKBb was detected (spot 0, Fig. 6C). A close
FIG. 4. PKBb is the predominant isoform in adipocytes. (A) Cell lysates (100 mg) from serum-starved 3T3-L1 fibroblasts (Fib) or 3T3-L1 adipocytes (Ad) were
depleted of PKBb by two consecutive rounds of immunoprecipitation with the sheep PKBb antibody. Twenty micrograms of lysate (Lysate) and one-fifth of the
immunoprecipitation supernatant (After PKBb-IP) were analyzed by SDS-PAGE and immunoblotting with the sheep PKBa or the sheep PKBb antibodies. (B) Cell
lysates (100 mg) from isolated rat adipocytes treated with 1 mM insulin (I) for 15 min or left basal (B) were depleted of PKBb and analyzed as described for panel A.
(C) Immunoprecipitation with the sheep PKBb antibody was performed on 100 mg of cell lysates prepared from 3T3-L1 adipocytes overexpressing HA-PKBa. The
immunoprecipitate (PKBb-IP) and 10 mg of lysate (Lysate) were analyzed by SDS-PAGE and immunoblotting for the presence of HA-PKBa, with a monoclonal HA
antibody.
FIG. 5. Insulin but not PDGF stimulates phosphorylation of PKBb in 3T3-L1 adipocytes. (A) PKB isoforms were immunoprecipitated from 100 mg of 3T3-L1 lysates
prepared from unstimulated cells (B) or cells treated with 1 mM insulin (I) or 50 ng of PDGF per ml (P) for 5 or 15 min. In the case of the PKBa immunoprecipitation,
PKBb was first depleted from the cell lysate by two consecutive rounds of immunoprecipitation. Immunoprecipitates were analyzed by SDS-PAGE and immunoblotting
with phospho-Ser473 (pSer473) or phospho-Thr308 (pThr308) PKB antibodies or the sheep PKBb antibody (PKBb). (B) PKBb was immunoprecipitated from
32P-labeled 3T3-L1 adipocytes treated with 1 mM insulin (I) or 50 ng of PDGF per ml (P) for 15 or left basal (B), by using the sheep PKBb antibody, and analyzed
by SDS-PAGE. The polyvinylidene difluoride membrane was subjected to autoradiography (autorad.) and then immunoblotted with the phospho-Ser473 antibody
(pSer473).
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examination of Fig. 6C shows that, under basal conditions, the
majority of PKBb is either unphosphorylated (spot 0) or
monophosphorylated (spot 1), with only a minor proportion
being dual phosphorylated (spot 2). Insulin stimulation caused
the complete disappearance of spot 0 with a significant in-
crease in the intensity of spot 2 and the appearance of spot 3
(Fig. 6D). The effect of PDGF stimulation on the 2D pattern
of PKBb spots was also examined. Consistent with previous
results (Fig. 2 and 5), stimulation of 3T3-L1 adipocytes with 50
ng of PDGF per ml for 15 min did not result in the leftward
shift of 2D PKBb spots observed in response to insulin (com-
pare Fig. 6C to E). In addition, pretreatment of cells with 100
nM wortmannin completely inhibited the insulin effect on the
PKBb 2D pattern (Fig. 6F), consistent with the reported PI3K
dependence of insulin-stimulated PKB activation.
Insulin stimulates PKBb translocation to the PM and HDM
fractions. Apart from phosphorylation, membrane transloca-
tion is thought to be required for activation of PKB. The
current model of PKB activation suggests that PKB is recruited
to the PM via its pleckstrin homology domain by the 39-phos-
phoinositides generated by the receptor-activated PI3K, where
it is phosphorylated at Ser473 and Thr308 by 39-phosphoino-
sitide-dependent kinase 1 (PDK1) and PDK2 (reviewed in
references 2 and 40). We and others have previously reported
that insulin and PDGF stimulate PI3K in adipocytes but that
the subcellular distribution of the enzyme is different in each
case (16, 41, 45). With PDGF, we observed a significant in-
crease in PI3K activity in the PM fraction, whereas with insulin,
it was enriched in a high-speed pellet (HSP) fraction associated
with IRS-1 and/or -2 (16). Thus, we next studied the distribu-
tion of PKBb among these fractions. Under basal conditions,
almost all the immunoreactive PKBb was found in the cytosol
(Fig. 7). In agreement with previous results, basal PKBb in the
cytosol fraction was resolved into two bands, corresponding to
bands 0 and 1 in Fig. 2A. A band detected in the HSP fraction
in the basal state exhibited apparent electrophoretic mobility
similar to that of band 0; however, in contrast to bands in the
cytosol, insulin did not induce an electrophoretic mobility shift
of the HSP band (Fig. 7). Insulin induced the translocation of
PKBb to the PM and high-density microsome (HDM) frac-
tions, while PDGF was without effect. This translocation does
not represent the association of PKBb with large protein com-
plexes because we find that it floats up through sucrose upon
sedimentation, consistent with a membrane-associated protein
(data not shown). Insulin-stimulated translocation of PKBb
was restricted to band 2, the activated form of PKBb, as con-
firmed by immunoreactivity to the phospho-Ser473 PKB anti-
body (Fig. 7). Interestingly, PKBb in the cytosol fraction un-
derwent an almost quantitative shift from band 0 to band 2
within 5 min of insulin stimulation, coincident with increased
Ser474 phosphorylation (Fig. 7). This suggests that either
PKBb was activated in the cytosol or it is activated at the PM
and rapidly translocates from this site to the cytosol.
Recent studies reporting the insulin-induced association of
PKBb with GLUT4-containing vesicles (12) and phosphoryla-
tion of its components (33) suggest that PKBb may directly
mediate GLUT4 translocation. In contrast to the report by
Calera et al. (12) for rat adipocytes, we did not detect PKBb in
membrane fractions in the basal state, nor did we observe
significant insulin-induced translocation of PKBb to the HSP
FIG. 6. Analysis of insulin-stimulated PKBb phosphorylation in 3T3-L1 adipocytes by 2-DE. 3T3-L1 adipocytes were 32P labeled and then stimulated without (A)
or with (B) 1 mM insulin for 15 min. PKBb was immunoprecipitated from cell lysates by using the rabbit anti-PKBb antibody and analyzed by 2-DE and
autoradiography. Lysates (150 mg) prepared from untreated 3T3-L1 adipocytes (C) or adipocytes treated with 1 mM insulin for 15 min (D), 50 ng of PDGF per ml for
15 min (E), or 100 nM wortmannin for 40 min with 1 mM insulin added for the last 15 min (F) were analyzed by 2-DE and immunoblotting with the rabbit anti-PKBb
antibody. Immunoblots of the polyvinylidene difluoride membranes from panels A and B yielded results similar to those for panels C and D.
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fraction (also termed the low-density microsome [LDM] frac-
tion) in 3T3-L1 adipocytes (Fig. 7). To further assess if PKBb
directly interacts with GLUT4 vesicles, we examined the ability
of insulin or PDGF to stimulate GLUT4 translocation in
3T3-L1 fibroblasts overexpressing both GLUT4 and PKBb.
Activation of PKBb by either insulin or PDGF did not alter the
subcellular location of GLUT4 in these cells (data not shown),
suggesting that activation of PKBb is not sufficient to stimulate
GLUT4 translocation in this system.
DISCUSSION
In the present study, we have provided further evidence to
support a role for the serine/threonine kinase PKB in insulin-
stimulated glucose transport in adipocytes. We show that a
PKB substrate peptide or an antibody to PKB inhibited insulin-
stimulated GLUT4 translocation by 66 and 56%, respectively.
Moreover, we have obtained evidence to implicate the PKBb
isoform in insulin action: (i) the expression of PKBb is sub-
stantially increased during adipocyte differentiation whereas
the expression of PKBa is markedly reduced during this pro-
cess, (ii) primary cultures of rat adipocytes have no detectable
immunoreactive PKBa, and (iii) insulin but not PDGF stimu-
lates PKBb phosphorylation and translocation to membranes
in 3T3-L1 adipocytes.
Previous studies have reported contradictory findings con-
cerning the role of PKB in insulin-stimulated glucose transport
(18, 23, 29, 30, 32, 54, 57, 59). We believe the present study
provides strong support for the involvement of PKB in insulin
action and clarifies some potential areas of contradiction that
have arisen. First, as discussed in more detail below, our study
implicates a role only for PKBb and not for PKBa in insulin
regulation of glucose transport in adipocytes. This may be
critical, as many previous studies have used reagents that either
specifically target PKBa or, as a minimum, have questionable
specificity for different PKB isoforms. Second, we have em-
ployed a strategy involving microinjection of either antibodies
or substrate peptides and then examination of the conse-
quences of these reagents for GLUT4 trafficking 60 to 90 min
later. This likely overcomes potential cellular adaptive mech-
anisms which could occur in response to expression of cDNAs
over a much longer time course.
Role of PKBa versus PKBb. Initial comparison of the rel-
ative expression of PKBa and PKBb in 3T3-L1 fibroblasts with
that in adipocytes by immunoblotting suggested that, while
PKBb was up-regulated, PKBa expression was not significantly
altered by adipocyte differentiation (Fig. 2C). However, as the
PKBa antibody was found to cross-react with PKBb (Fig. 2B),
part of the PKBa immunoreactivity in 3T3-L1 adipocytes likely
represented PKBb, which is highly expressed in these cells. We
tested this hypothesis by depleting PKBb from cell lysates prior
to immunoblotting with the PKBa antibody and found that,
indeed, most of the PKBa immunoreactivity in adipocytes was
removed by PKBb depletion (Fig. 4A). In contrast, substantial
PKBa immunoreactivity remained after PKBb depletion of
fibroblast lysates (Fig. 4A). Consistent with our findings in
3T3-L1 adipocytes, we also find that there is very little PKBa
in rat adipocytes, with PKBb being the major isoform (Fig.
4B). Based on the present studies, we predict that previous
reports of insulin-activated PKBa activity in rat adipocytes may
be due to antibody cross-reactivity.
These results suggest that there is a switch in isoform ex-
pression during differentiation of fibroblasts into adipocytes.
As PKBa and PKBb are 81% identical in amino acid sequence,
the specific change in isoform expression upon adipocyte dif-
ferentiation is likely to be functional. Fibroblasts represent a
highly proliferative cell type, and so it seems likely that PKBa
is important in the regulation of cell growth and proliferation,
and its down-regulation upon differentiation is appropriate as
adipocytes are terminally differentiated and not proliferative.
On the other hand, the induction of PKBb expression during
adipocyte differentiation parallels that observed for GLUT4
(Fig. 3A), implying a role for PKBb in metabolic regulation in
adipocytes. Further support comes from our observation that
rat adipocytes express high levels of PKBb (Fig. 4B) and from
the reported high PKBb mRNA expression in brown adipose
tissue (3). An induction of PKBb mRNA was also observed
upon differentiation of Sol8 muscle cells (13) and C2C12 myo-
tubes (3), supporting a role for PKBb in insulin regulation of
metabolism in muscle cells in addition to adipocytes. In our
study, no PKBb expression was observed in subconfluent,
highly proliferative fibroblasts. A slight increase in PKBb ex-
pression was observed when cells became confluent in culture,
followed by a more dramatic induction when fibroblasts differ-
entiated into adipocytes (Fig. 3). Taken together, these obser-
vations suggest that the expression of PKBb is normally re-
stricted to terminally differentiated, nonproliferative cells,
where PKBb plays a role in metabolic regulation. The inap-
FIG. 7. Insulin, but not PDGF, stimulates the translocation of PKBb to membrane fractions in 3T3-L1 adipocytes. 3T3-L1 adipocytes were stimulated with insulin
(I) or PDGF (P) for 5 or 15 min or left basal (B). Cells were homogenized and subfractionated by differential centrifugation as described in Materials and Methods,
to generate the PM, HDM, HSP (also termed LDM), cytosol (CYT), and the mitochondrial-nuclear (M/N) fractions. Twenty micrograms of each fraction was analyzed
by SDS-PAGE and immunoblotting with the sheep PKBb (PKBb) or the phospho-Ser473 PKB (pSer473) antibody.
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propriate expression of PKBb in undifferentiated cells can lead
to uncontrolled cell proliferation as demonstrated by the trans-
forming ability of PKBb when overexpressed in NIH 3T3 cells
(15). Overexpression of constitutively active PKBa in 3T3-L1
fibroblasts leads to spontaneous differentiation into adipocytes
(36). To further address the roles of different PKB isoforms, it
may be of interest to compare the effects of overexpressing
constitutively active PKBb or PKBg to that observed for PKBa
in 3T3-L1 fibroblasts.
Activation of PKBb is insulin specific in 3T3-L1 adipocytes.
Several recent studies have compared the signaling of insulin
with that of PDGF in adipocytes, based on the hypothesis that
the inability of PDGF to induce glucose uptake reflects its
inability to activate a relevant downstream signaling path-
way(s). Indeed, several groups have reported differences be-
tween the subcellular location of PI3K activated by insulin and
that of PI3K activated by PDGF (16, 41, 45). Furthermore,
PDGF was found to have little effect on the levels of phospha-
tidylinositol 3,4,5-trisphosphate (PIP3) in 3T3-L1 adipocytes,
whereas insulin induced a significant increase (19). These re-
sults suggest that, while PI3K is activated by recruitment to
activated PDGF receptors at the PM in 3T3-L1 adipocytes, it
may not have access to appropriate substrates and thus is
unable to produce a rise in PIP3. In agreement with the lack of
PDGF-induced PIP3 production, we found no effect of PDGF
on PKBb phosphorylation in 3T3-L1 adipocytes by electro-
phoretic mobility shift, immunoprecipitation in conjunction
with 32P labeling or immunoblotting with phosphospecific an-
tibodies, or isoelectric point shifts analyzed by 2-DE. Further-
more, PDGF did not stimulate membrane translocation of
PKBb, as observed with insulin, nor did it have a transient
effect on PKBb phosphorylation (Fig. 5A). The insulin speci-
ficity further supports a role for PKBb in the regulation of
glucose metabolism in adipocytes.
Three previous studies have reported variable effects of
PDGF on PKB in 3T3-L1 adipocytes (10, 51, 54). Two studies
utilized phospho-Ser473 PKB antibodies and found a small
PDGF-induced PKB phosphorylation (;20% of insulin ef-
fect). We were unable to detect PDGF-stimulated PKB phos-
phorylation in 3T3-L1 adipocytes treated with 50 ng of PDGF
per ml with the same antibody in immunoblotting of cell lysates
(Fig. 2A), but very weak PDGF-induced PKBb phosphoryla-
tion was sometimes observed in immunoprecipitates (Fig. 5A).
Tanti et al. observed a significant PDGF-stimulated activation
of PKB (to 50% of the insulin effect) in 3T3-L1 adipocytes by
immunoprecipitation-coupled kinase assays (54). The reason
for the discrepancy between these studies is not clear. One
possible explanation is differences in the integrity of 3T3-L1
adipocyte cultures. As PKBa is the predominant isoform in
3T3-L1 fibroblasts and is strongly activated by PDGF in these
cells, an increased level of fibroblast contamination of adipo-
cyte cultures may give rise to a PDGF response on PKB. This
may be further amplified in the case of immunoprecipitation
with an antibody with a high affinity for PKBa.
Regulation of PKBb activation in 3T3-L1 adipocytes. A
synthesis of our data concerning activation of PKBb in 3T3-L1
adipocytes suggests that both unphosphorylated (band 0 and
spots 0) and phosphorylated (band 1 and spots 1 and 2) PKBb
are present in basal adipocytes. Furthermore, separation of
phospho-PKB into two spots with different pI suggests that
there are two populations of differentially phosphorylated
forms of PKBb in basal 3T3-L1 adipocytes. Constitutive phos-
phorylation of PKBb in 3T3-L1 adipocytes does not occur on
either Ser474 or Thr309, because no significant signal was
detected with phospho-PKB antibodies in basal adipocytes
(Fig. 2A and 5A). Two constitutive phosphorylation sites have
been reported for PKBb transfected into HEK-293 cells, and
these are Ser125 and Thr451 (39). Thus one interpretation of
our results is that ;50% of PKBb is constitutively phosphor-
ylated, possibly on either Ser125 or Thr451 in the basal state in
3T3-L1 adipocytes (spot 1), while a small amount is dual phos-
phorylated on both residues, resulting in a more acidic pI (spot
2). Insulin caused the total disappearance of nonphosphory-
lated PKBb (spot 0), with an increase in the immunoreactivity
of spots 2 and 3, concomitant with insulin-induced phosphor-
ylation (Fig. 6A to D). A recent study suggests that constitutive
phosphorylation at Thr450 primers PKBa for subsequent
growth factor stimulation when expressed in NIH 3T3 cells (9).
Thus, one possibility is that insulin stimulates phosphorylation
of basally unphosphorylated PKBb (spot 0) on one or both of
the constitutive sites (Ser125 and Thr451) but that only basally
phosphorylated PKBb (spots 1 and 2) becomes phosphorylated
on activating sites (Ser474 and Thr309). As the present data
does not provide information on the sites of phosphorylation
of the differentially charged PKBb isoforms, further investiga-
tion is required to confirm this hypothesis in 3T3-L1 adipo-
cytes. Interestingly, only a single band which exhibits an elec-
trophoretic mobility that is intermediate between bands 0 and
1 was observed in rat adipocytes. Upon insulin stimulation, the
entire band shifts to a position corresponding to band 2. The
phosphorylation state of the basal band in rat adipocytes is yet
to be determined and should provide valuable data on the role
of constitutive phosphorylation.
Current models of growth factor-stimulated PKB activation
suggest that the products of PI3K recruit both PDK1 and PKB
to the PM, where PDK1 phosphorylates and activates PKB (2,
4, 40). The requirement for membrane translocation in PKB
activation is supported by the finding that forced translocation
to the PM by myristoylation-palmitylation is sufficient to in-
duce PKB phosphorylation at Thr308 and Ser473 (5). In the
present study, we observed specific translocation of phosphor-
ylated PKBb to the PM and HDM fractions in response to
insulin treatment of 3T3-L1 adipocytes. In agreement with the
inability of PDGF to induce PKBb phosphorylation, no mem-
brane translocation was observed in response to PDGF stim-
ulation. Interestingly, while some PKBb remained associated
with the PM and the HDM, a major portion of activated PKBb
was observed in the cytosol within 5 min of insulin stimulation
(Fig. 7). These results suggest that either PKBb can be acti-
vated in the cytosol or, more likely, following activation at the
membrane, most PKBb returns to the cytosol where it is able
to phosphorylate its physiological substrates. Recent reports of
insulin-induced association of PKBb with GLUT4-containing
vesicles (12) and phosphorylation of its components (33) sug-
gest that PKBb may directly regulate the GLUT4 translocation
machinery. We did not observe any significant recruitment of
PKBb to the HSP-LDM fraction which contains the insulin-
responsive pool of GLUT4 in 3T3-L1 adipocytes. However, it
is possible that our assay is not sensitive enough to detect a low
level of PKBb recruitment to this fraction. Thus, we further
tested the hypothesis that PKBb directly mediates GLUT4
translocation by examining the effect of activating PKBb by
insulin or PDGF in 3T3-L1 fibroblasts expressing both PKBb
and GLUT4. Neither insulin nor PDGF stimulated GLUT4
translocation in these cells, suggesting that either another sig-
naling pathway is required or fibroblasts lack the expression of
downstream signaling molecules or machinery required for
GLUT4 translocation.
In summary, our data implicates an important role for PKB
in insulin action in adipocytes. We cannot exclude a role for
alternate parallel pathways such as PKCl and/or PKCz. Using
microinjection of either a PKB substrate peptide or a PKB
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antibody, we observed a ;60% inhibition of insulin-stimulated
GLUT4 translocation to the PM. Hence, it is conceivable that
the residual insulin action is due to a PKB-independent path-
way. Further effort is required to identify this alternate path-
way and to identify downstream targets of PKBb in adipocytes.
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